Home › Hemophilia B › Texas › Houston
Hemophilia B clinical trials in Houston, TX
4 studies for Hemophilia B are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
RecruitingPhase 1/2
- University of Texas Health Science Center at Houston, Houston
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
RecruitingPhase 3
- The University of Texas Health Science Center at Houston, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
RecruitingPhase 4
- Gulf States Hemophilia and Thrombophilia Center-University of Texas Health Science Center @Houston, Houston
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Sacramento, CA4 studies
- Atlanta, GA4 studies
- Ann Arbor, MI4 studies
- Los Angeles, CA4 studies
- Seattle, WA3 studies
- San Francisco, CA3 studies
- Indianapolis, IN3 studies
- Gainesville, FL3 studies
- Nashville, TN3 studies
- Greenville, NC3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.